MSB 3.19% 97.0¢ mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-12

  1. 7,865 Posts.
    lightbulb Created with Sketch. 621
    What gets me is we know they read HC but are still slow off the mark with releasing their announcements I realise ASX vet all announcements which slows the release, but to me it seems that they are not as pro active as I would expect I don’t want to be notified about trivial marketing fluff but this should have hit the ASX desk last night so it was first cab off the rank this morning It is better than 9.55am LOL
    Last edited by stocksa: 21/07/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.0¢
Change
0.030(3.19%)
Mkt cap ! $1.107B
Open High Low Value Volume
94.0¢ 98.0¢ 92.0¢ $3.342M 3.477M

Buyers (Bids)

No. Vol. Price($)
4 33313 97.0¢
 

Sellers (Offers)

Price($) Vol. No.
97.5¢ 73982 2
View Market Depth
Last trade - 16.10pm 03/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.